Tactile Systems Technology Inc

NASDAQ TCMD

Data sourced from

and

Download Data

Tactile Systems Technology Inc Operating Cash Flow to Sales Ratio 1 year YoY Change (%) for the quarter ending March 31, 2024: 277.31%

Tactile Systems Technology Inc Operating Cash Flow to Sales Ratio 1 year YoY Change (%) is 277.31% for the quarter ending March 31, 2024, a 184.80% change year over year. The operating cash flow to sales ratio measures the proportion of a company's operating cash flow to its total sales revenue. It is calculated by dividing the operating cash flow by the revenue. This ratio indicates the company's ability to convert its sales revenue into operating cash flow, reflecting its operational efficiency and cash generation capabilities. A higher ratio suggests a higher level of cash flow generated from sales, indicating strong profitability and effective cash management. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

Tactile Systems Technology Inc Operating Cash Flow to Sales Ratio for the quarter ending March 31, 2023 was -0.85%, a 97.37% change year over year.
Tactile Systems Technology Inc Operating Cash Flow to Sales Ratio for the quarter ending March 31, 2022 was -32.45%, a -1,634.84% change year over year.
Tactile Systems Technology Inc Operating Cash Flow to Sales Ratio for the quarter ending March 31, 2021 was -1.87%, a -189.87% change year over year.
Tactile Systems Technology Inc Operating Cash Flow to Sales Ratio for the quarter ending March 31, 2020 was 2.08%, a -38.50% change year over year.

NASDAQ: TCMD

Tactile Systems Technology Inc

CEO	Mr. Daniel L. Reuvers
IPO Date	July 28, 2016
Location	United States
Headquarters	3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416
Employees	992
Sector	Healthcare
Industry	Medical devices

Description

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Key trends